Private Advisor Group’s TG Therapeutics TGTX Stock Holding History

Private Advisor Group’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$265K	Buy	+4,759	New	+$258K	﹤0.01%	2676
2025 Q2	–	Sell	-9,391	Closed	-$370K	–	2572
2025 Q1	$370K	Sell	9,391 -3,050	-25%	-$103K	﹤0.01%	1756
2024 Q4	$374K	Sell	12,441 -1,966	-14%	-$56.4K	﹤0.01%	1739
2024 Q3	$337K	Buy	14,407 +542	+4%	+$11.8K	﹤0.01%	1860
2024 Q2	$247K	Buy	13,865 +292	+2%	+$4.66K	﹤0.01%	2021
2024 Q1	$206K	Sell	13,573 -61	-0.4%	-$972	﹤0.01%	2093
2023 Q4	$233K	Buy	+13,634	New	+$158K	﹤0.01%	1957
2020 Q3	–	Sell	-2,655	Closed	-$52K	–	3233
2020 Q2	$52K	Buy	+2,655	New	+$42.8K	﹤0.01%	2089

Other funds holding TGTX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return

Private Advisor Group's TGTX Position: Q3 2026 in Review

Private Advisor Group opened a new position in TG Therapeutics (TGTX) in Q3 2026: 4,759 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #2676 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in TGTX as recently as Q1 2025.

Private Advisor Group first reported a position in TGTX in Q2 2020 and has held it in 8 quarters since. The position peaked at $374K in Q4 2024. 258 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

Private Advisor Group held 4,759 shares of TG Therapeutics worth $265K as of Q3 2026.
TG Therapeutics was a new Private Advisor Group position in Q3 2026.
TG Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #2676 holding.
Private Advisor Group first reported a position in TG Therapeutics in Q2 2020 and has held it in 8 quarters since.
Private Advisor Group's TG Therapeutics position peaked at $374K in Q4 2024.
258 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.